A 53-year-old woman with non-Hodgkin lymphoma underwent an autologous bone marrow transplant (BMT). Incomplete reconstitution necessitated the use of a long-term central venous catheter. One year after BMT she presented with fever. Echocardiography revealed vegetations on the tricuspid valve. Gram-positive rods grown from blood cultures and catheter tip were identified as Oerskovia xanthineolytica. We report the first case of native valve endocarditis caused by this organism. Keywords: Oerskovia xanthineolytica; autologous bone marrow transplantation; central venous catheter; endocarditis Oerskovia species are Nocardia-like Gram-positive bacteria, first described by Orskov in 1938 as an inhabitant of soil.
daily) the fever persisted. A blood culture taken from the Hickman catheter showed Gram-positive rods, later identified as Oerskovia species. The catheter was removed, and the same bacteria were cultured from the catheter tip. Meanwhile, oral therapy with clindamycin 300 mg four times daily had been started and was discontinued 2 days after removal of the catheter.
Two weeks later the patient was admitted because of persisting fever and somnolence. Meropenem 2 g three times daily was started, which is the standard therapy in our hospital for unexplained fever in granulopenic patients. Two blood cultures taken on 2 consecutive days again revealed Oerskovia xanthineolytica. An extensive search for the focus of the infection was performed. Abdominal ultrasound and CT scans of cerebrum, thorax and abdomen showed no abnormalities. Transthoracic echocardiography revealed vegetations on the tricuspid valve without signs of valvular dysfunction, combined with repeatedly positive blood cultures leading to the diagnosis of infective endocarditis, 18 probably caused by bacterial contamination of the Hickman catheter. The patient responded well to meropenem and blood cultures remained negative. The antibiotic regimen was changed after 3 weeks into trimethoprimsulfamethoxazole (960 mg twice daily) and amoxicillin (6 × 2 g) intravenously because of good results with this regimen reported in the literature in a case of Oerskovia turbata endocarditis.
One week after cessation of therapy the fever relapsed, and again Oerskovia xanthineolytica was cultured from one blood culture. As the patient was not eligible for cardiac surgery, treatment with trimethoprim-sulfamethoxazole and amoxicillin was again started; this time oral administration was chosen on an out-patient basis. Because of unacceptable side-effects (nausea and vomiting), the patient was readmitted and the antibiotic treatment was changed to imipenem/cilastatin 500 mg twice daily and amikacin 600 mg twice daily intravenously for 3 weeks, followed by clarithromycin and rifampicin orally. These regimens have been described in literature as the most effective treatment in nocardiosis. However, during treatment with the latter regimen another bacteremic episode occurred. Penicillin intravenously was started empirically to which the patient responded well. Shortly thereafter, the patient developed neurological symptoms based on intracerebral relapse of non-Hodgkin lymphoma. The patient died 2 weeks later.
During the course of the infection six blood cultures became positive in the BacT\Alert blood culture system (Organon Teknika, Boxtel, The Netherlands). Gram-stain showed Gram-positive diphtheroid-like branching rods. Subcultures on Columbia blood agar and Schaedler anaerobic agar revealed yellow, catalase positive, oxidase negative colonies within 24 h of incubation in both the aerobic and anaerobic environments. The API Coryne system (BioMerieux, Marcy l'Etoile, France) identified the bacterium as Oerskovia species. The bacterium showed growth at 42°C and hydrolyzed xanthine and hypoxanthine. The isolated bacteria were identified to the species level as Oerskovia xanthineolytica by reference laboratory: the National Institute for Public Health and Environment in Bilthoven, The Netherlands.
Susceptibility testing was done by E-test antimicrobial gradient strip (AB Biodisk, Solna, Sweden) on Isosensitest Agar (Oxoid, Durham, UK) as shown in Table 1 . Susceptibility of the bacterium to rifampicin was shown by disk diffusion. However, after 2 weeks of treatment the bacterium was shown to be resistant using E-test (MIC 6 g/ml). The bactericidal test (microdilution method) was performed for amoxycillin and TMP-SMX but could not be interpreted due to clumping of the bacteria.
Discussion
Oerskovia species were first isolated and described in 1938 by Orskov as motile Nocardia. 1 In the early seventies several other bacteriologists described this nocardioform actinomycete. [2] [3] [4] The species are found in organic material, plants and brewery sewage. These non-acid fast, Grampositive bacteria grow well on agar-and broth-based media. Within 24 to 48 h, yellow pigmented colonies can be seen without aerial hyphae, differentiating this species from Nocardia. 4 The API Coryne system has been shown to reliably identify Oeskovia species. 5 Two motile species are described, O. turbata and O. xanthineolytica, which can be distinguished by the ability to hydrolyze xanthine and hypoxanthine. For Nocardia species, E-tests have been shown to correlate well with broth microdilution methods, 6 but correlation between in vitro susceptibility testing of Oerskovia species and outcome of treatment is uncertain due to limited experience with these infections. Oerskovia-related infections have only been described sporadically. Although the Center for Disease Control (Atlanta, GA, USA) collected more than 35 isolates over a 20-year period, only 15 cases have been described in the literature. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Four cases concerned infection with Oerskovia turbata, nine with Oerskovia xanthineolytica, and two remained undetermined. In 10 patients infection was associated with a foreign body, which was removed as part of the treatment in eight patients. All patients but one were immunocompromised. Only one case of Oerskovia-related endocarditis has been described concerning an Oerskovia turbata infection in a patient with an aortic valve homograft replacement. Despite antibiotic treatment, complete recovery was achieved only after homograft replacement. 7 Our report describes an immunocompromised patient with incomplete repopulation after bone marrow transplant, who needed a central venous catheter for regular transfusions. Colonization of the catheter with Oerskovia xanthineolytica probably led to endocarditis.
Despite intensive antibiotic treatment, the bacteremia relapsed several times. In vivo susceptibility of Oerskovia xanthineolytica to the antibiotic regimens used seems likely, as symptoms disappeared quickly during antibiotic treatment with carbapenems, and the combination of amoxicillin and trimethoprim-sulfamethoxazole. Therefore, either duration of the treatment was too short, or antibiotic penetration of the valve was insufficient, indicating that surgical replacement would have been necessary. However, cardiac surgery seemed inappropriate in this patient with poor bone marrow function. Therefore the only remaining therapeutic option was long-term antibiotic treatment, preferably orally. Side-effects ruled out long-term treatment with amoxicillin and trimethoprim-sulfamethoxazole. Use of oral rifampicin and clarithromycin led to resistance to rifampicin in vitro and probably in vivo. Shortly thereafter, the patient suffered from a relapse of intracerebral nonHodgkin lymphoma, and she died within 2 weeks.
This case report confirms the risk of the presence of indwelling central venous catheters for prolonged periods of time, particularly in immunocompromised patients. Our case presents the first Oerskovia-related infection after bone marrow transplant. We conclude that in immunocompromised patients relatively avirulent bacteria like Oerskovia species can be a cause of severe infection, especially in the presence of a foreign body.
